NCT00384228
- Conditions
- Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Bone Marrow Diseases, Chronic Disease, +18 more
- Locations
-
- Novartis Investigative Site Tokyo, Japan
Clinical trial condition
Chronic Myelogenous Leukemia
Explore clinical trials studying Chronic Myelogenous Leukemia. Study availability and eligibility vary by location and protocol.
112 public trials
10 recruiting studies
Chronic Myelogenous Leukemia trial results
- Conditions
- Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Chronic Disease, +18 more
- Locations
-
- Novartis Investigative Site Aichi, Japan
NCT02181478
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +35 more
- Locations
-
- Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT00309842
- Conditions
- Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Anemia, +66 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT01274351
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
- Locations
-
- Novartis Investigative Site Eskişehir, Meselik, Turkey (Türkiye)
- Novartis Investigative Site Istanbul, TUR, Turkey (Türkiye)
- Novartis Investigative Site Adana, Turkey (Türkiye)
- Novartis Investigative Site Ankara, Turkey (Türkiye)
NCT01611298
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +27 more
- Locations
-
- Texas Childen's Hospital Houston, Texas, United States
- The Methodist Hospital Houston, Texas, United States
NCT00368355
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +32 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
- Texas Children's Hosptial Houston, Texas, United States
NCT00723099
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +63 more
- Locations
-
- University of Colorado Hospital Aurora, Colorado, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- LDS Hospital Salt Lake City, Utah, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
Completed
Nilotinib + Pegylated Interferon Alpha 2a for Untreated Chronic Phase Chronic Myelogenous Leukemia
NCT01294618
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
- Locations
-
- Hospices Civils de Lyon Lyon, France
NCT02208037
- Conditions
- Acute Leukemia, Anemia, Anemia, Refractory, +35 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- Stanford Hospital and Clinics Stanford, California, United States
- University of Florida College of Medicine (Shands) Gainesville, Florida, United States
- H. Lee Moffitt Cancer Center Tampa, Florida, United States